Machida, Japan

Akihiro Izumi


Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Kawasaki, JA (1976 - 1977)
  • Kawasaki, JP (1982)
  • Machida, JP (1986 - 1989)

Company Filing History:


Years Active: 1976-1989

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Akihiro Izumi: Innovator in Antihypertensive Compounds

Introduction

Akihiro Izumi is a notable inventor based in Machida, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive agents. With a total of five patents to his name, Izumi's work has the potential to impact the treatment of hypertension.

Latest Patents

Izumi's latest patents include innovative compounds that serve as antihypertensive agents. One of his notable inventions is a pyridazinone derivative, which is represented by a specific general formula. This compound is designed to be effective in lowering blood pressure. Another significant patent involves a hydrazinopyridazine compound, which also has applications as an antihypertensive agent. The detailed chemical structures and functionalities of these compounds highlight Izumi's expertise in medicinal chemistry.

Career Highlights

Izumi is currently employed at Teikoku Hormone Mfg. Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a focus on developing effective treatments for hypertension, showcasing his commitment to improving patient health outcomes.

Collaborations

Throughout his career, Izumi has collaborated with esteemed colleagues such as Kunio Tsukamoto and Yasushi Suzuki. These partnerships have likely contributed to the success and development of his innovative compounds.

Conclusion

Akihiro Izumi's contributions to the field of antihypertensive agents through his patents reflect his dedication to pharmaceutical innovation. His work continues to pave the way for advancements in hypertension treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…